South Korea Animal Drug Compounding Market Insight
Published: 04 June 2026 | Report Format: Electronic (PDF)
The growth rate of the animal drug compounding market in South Korea is expected to grow at a rate of 6.96% owing to increasing veterinary healthcare demand, rising pet ownership, and growing animal treatment customization requirements
South Korea Animal Drug Compounding Market Insights Forecasts to 2035
- The South Korea Animal Drug Compounding Market Size Was Estimated USD 142.8 Million in 2025
- The Market Size is Expected to Grow at a CAGR of around 6.96 % from 2025 to 2035
- The South Korea Animal Drug Compounding Market Size is Expected to rise around USD 279.9 Million by 2035
Notable Insights for the South Korea Animal Drug Compounding Market
- Based on the Segmentation by Product Type, customized oral medications & Injectable veterinary compounds segment is taking lead in South Korea Animal Drug Compounding Market in 2025, holding almost 55% due to increasing veterinary prescription demand.
- Based on the Segmentation by Application, companion animals & veterinary Clinics segment held a market share of about 62% in South Korea Animal Drug Compounding Market in 2025, mainly driven by rising pet healthcare treatment requirements.
- The global revenue of Dechra Pharmaceuticals PLC in fiscal year 2025 stood at nearly $2.3 billion backed by growing demands for veterinary pharmaceuticals, animal healthcare solutions, and compounded treatment medications.
Download the eBook (ToC)
- Increasing investments in veterinary healthcare technologies, customized animal medications, and advanced pharmaceutical compounding systems will fuel the growth of the market in coming years, as compounded veterinary drugs improve treatment effectiveness up to 41% and dosage accuracy up to 27%.
What Makes Decisions Advisors Research Unique?
- Intelligent Market Research Based on AI for Veterinary Healthcare
Decisions Advisors offers intelligent market research which includes advanced analysis of veterinary pharmaceuticals, animal healthcare technologies, customized treatment solutions, and drug compounding systems. Our research identifies potential areas of business development, technology adoption rates, competitive position analysis, and important strategic changes in South Korea Animal Drug Compounding Market.
- Highly Effective Research Approaches with Accurate Forecast Analysis
The research process uses advanced methodologies such as primary research interview approaches, veterinary healthcare research, pharmaceutical value chain tracking, and data triangulation to deliver accurate market sizing, CAGR forecasting, investment analysis, and technology forecasting. The study examines the demand for compounded animal drugs in veterinary clinics, animal hospitals, livestock treatment, and companion animal healthcare applications in South Korea.
- Highly Competitive Environment Analysis
In-depth analysis of key veterinary pharmaceutical companies, compounded drug innovations, animal healthcare technologies, product launch activities, and collaborations is included in the report. The report also covers veterinary regulations, pharmaceutical research and development analysis, animal healthcare infrastructure, and new opportunities available in the South Korea Animal Drug Compounding Market.
Competitive Analysis:
The report offers the appropriate analysis of the key organizations/companies involved within the South Korea Animal Drug Compounding Market, along with a comparative evaluation primarily based on their product of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
Top Companies in South Korea Animal Drug Compounding Market
• Dechra Pharmaceuticals PLC
• Wedgewood Pharmacy
• Covetrus, Inc.
• Elanco Animal Health Incorporated
• Zoetis Inc.
• Boehringer Ingelheim International GmbH
• Vetoquinol S.A.
• Virbac
• Ceva Santé Animale
• Bimeda, Inc.
Recent Developments:
- In September 2025, Dechra Pharmaceuticals PLC introduced customized veterinary compounding solutions integrated with advanced dosage formulation technologies for companion animal healthcare applications.
- In April 2025, Zoetis Inc. launched next-generation compounded animal medications optimized for veterinary clinics, livestock treatment, and precision animal healthcare systems.
Market Segmentation:
South Korea Animal Drug Compounding Market, By Product Type
- Customized Oral Medications
- Injectable Veterinary Compounds
- Topical Veterinary Preparations
- Flavored Animal Medications
- Sterile Compounded Drugs
South Korea Animal Drug Compounding Market, By Technology
- Precision Veterinary Compounding Systems
- AI-Based Dosage Monitoring Technologies
- Customized Pharmaceutical Formulation Platforms
- Smart Veterinary Healthcare Solutions
- Advanced Sterile Drug Preparation Technologies
South Korea Animal Drug Compounding Market, By Application
- Companion Animals
- Veterinary Clinics
- Livestock Treatment
- Animal Hospitals
- Specialized Veterinary Care
Expert Views:
The South Korean animal drug compounding market will experience growth owing to increasing veterinary healthcare demand, rising pet ownership, and growing customized animal treatment requirements. The combination of precision veterinary compounding technologies, AI-enabled dosage monitoring systems, and advanced pharmaceutical formulation platforms will improve treatment effectiveness and drive demand in veterinary clinics, animal hospitals, livestock healthcare, companion animal treatment, and specialized veterinary applications
Author: Komal and Radhika By Spherical Insights and Consulting